Gao-Jun Teng, M.D.
Zhongda hospital, Southeast university, Nanjing, China
5
5
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Hai-Peng Wang, M.D.
Zhongda hospital, Southeast university, Nanjing, China
Shared therapeutic areas:
Worked with same sponsors:
Xiaolong Qi, M.D.
Zhongda hospital, Southeast university, Nanjing, China
Shared therapeutic areas:
Worked with same sponsors:
Zheng-Gang Ren, M.D.
Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
Shared therapeutic areas:
Worked with same sponsors:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Worked with same sponsors:
Ming Shi, MD
Sun Yat-sen University
Shared therapeutic areas:
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Zhongrong Miao, MD
Beijing Tiantan Hospital
Shared therapeutic areas:
Yongjun Wang, MD
Beijing Tiantan Hospital
Shared therapeutic areas:
Saleh K Saleh, MD
Minia University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC
Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
All 5 trials loaded